Gadolinium use for interventional pain procedures: where we are and where we are heading

Research output: Contribution to journalArticle

Abstract

In recent years as the use of interventional pain procedures has soared, so too has outside and internal scrutiny. This scrutiny includes agreater emphasis on weighing the risks and benefits of procedures, increased surveillance for adverse events, and cost containment strategies. In 2016, the first reports of gadolinium deposition in the central nervous system began to surface, though retention in other organ systems has been appreciated for over a decade. In this issue of Regional Anesthesia & Pain Medicine, Benzon et al. report a series of patients with document edhypersensitivity reactions to iodinated contrast medium who were inadvertently administered iodine-based contrast without adverse consequences. In this article, we discuss the epidemiology of contrast-mediated adverse effects, the mechanistic basis for hypersensitivity reactions, the risks and benefits of various approaches in the patient with a documented contrast hypersensitivity reaction, and risk mitigation strategies.

Original languageEnglish (US)
Pages (from-to)4-6
Number of pages3
JournalRegional Anesthesia and Pain Medicine
Volume44
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Gadolinium
Hypersensitivity
Pain
Conduction Anesthesia
Cost Control
Iodine
Contrast Media
Epidemiology
Central Nervous System
Medicine

Keywords

  • chronic pain: imaging
  • interventional pain management
  • pain medicine

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

@article{def07680ee794b74a118633bcfc99d5a,
title = "Gadolinium use for interventional pain procedures: where we are and where we are heading",
abstract = "In recent years as the use of interventional pain procedures has soared, so too has outside and internal scrutiny. This scrutiny includes agreater emphasis on weighing the risks and benefits of procedures, increased surveillance for adverse events, and cost containment strategies. In 2016, the first reports of gadolinium deposition in the central nervous system began to surface, though retention in other organ systems has been appreciated for over a decade. In this issue of Regional Anesthesia & Pain Medicine, Benzon et al. report a series of patients with document edhypersensitivity reactions to iodinated contrast medium who were inadvertently administered iodine-based contrast without adverse consequences. In this article, we discuss the epidemiology of contrast-mediated adverse effects, the mechanistic basis for hypersensitivity reactions, the risks and benefits of various approaches in the patient with a documented contrast hypersensitivity reaction, and risk mitigation strategies.",
keywords = "chronic pain: imaging, interventional pain management, pain medicine",
author = "Shravani Durbhakula and Steven Cohen",
year = "2019",
month = "1",
day = "1",
doi = "10.1136/rapm-2018-100163",
language = "English (US)",
volume = "44",
pages = "4--6",
journal = "Regional Anesthesia and Pain Medicine",
issn = "1098-7339",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Gadolinium use for interventional pain procedures

T2 - where we are and where we are heading

AU - Durbhakula, Shravani

AU - Cohen, Steven

PY - 2019/1/1

Y1 - 2019/1/1

N2 - In recent years as the use of interventional pain procedures has soared, so too has outside and internal scrutiny. This scrutiny includes agreater emphasis on weighing the risks and benefits of procedures, increased surveillance for adverse events, and cost containment strategies. In 2016, the first reports of gadolinium deposition in the central nervous system began to surface, though retention in other organ systems has been appreciated for over a decade. In this issue of Regional Anesthesia & Pain Medicine, Benzon et al. report a series of patients with document edhypersensitivity reactions to iodinated contrast medium who were inadvertently administered iodine-based contrast without adverse consequences. In this article, we discuss the epidemiology of contrast-mediated adverse effects, the mechanistic basis for hypersensitivity reactions, the risks and benefits of various approaches in the patient with a documented contrast hypersensitivity reaction, and risk mitigation strategies.

AB - In recent years as the use of interventional pain procedures has soared, so too has outside and internal scrutiny. This scrutiny includes agreater emphasis on weighing the risks and benefits of procedures, increased surveillance for adverse events, and cost containment strategies. In 2016, the first reports of gadolinium deposition in the central nervous system began to surface, though retention in other organ systems has been appreciated for over a decade. In this issue of Regional Anesthesia & Pain Medicine, Benzon et al. report a series of patients with document edhypersensitivity reactions to iodinated contrast medium who were inadvertently administered iodine-based contrast without adverse consequences. In this article, we discuss the epidemiology of contrast-mediated adverse effects, the mechanistic basis for hypersensitivity reactions, the risks and benefits of various approaches in the patient with a documented contrast hypersensitivity reaction, and risk mitigation strategies.

KW - chronic pain: imaging

KW - interventional pain management

KW - pain medicine

UR - http://www.scopus.com/inward/record.url?scp=85060009998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060009998&partnerID=8YFLogxK

U2 - 10.1136/rapm-2018-100163

DO - 10.1136/rapm-2018-100163

M3 - Article

C2 - 30640646

AN - SCOPUS:85060009998

VL - 44

SP - 4

EP - 6

JO - Regional Anesthesia and Pain Medicine

JF - Regional Anesthesia and Pain Medicine

SN - 1098-7339

IS - 1

ER -